Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)AZD7325
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine whether AstraZeneca's drug AZD7325 is safe
and effective in the treatment of generalized anxiety disorder.